Total Payments
$251,257
2024 Payments
$17,018
Companies
36
Transactions
857
Medicare Patients
2,526
Medicare Billing
$285,623
Payment Breakdown by Category
Other$223,719 (89.0%)
Food & Beverage$15,652 (6.2%)
Travel$11,784 (4.7%)
Education$101.20 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $223,719 | 111 | 89.0% |
| Food and Beverage | $15,652 | 703 | 6.2% |
| Travel and Lodging | $11,784 | 41 | 4.7% |
| Education | $101.20 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $174,795 | 451 | $0 (2024) |
| Allergan, Inc. | $39,463 | 232 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $18,287 | 37 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $13,376 | 14 | $0 (2022) |
| PFIZER INC. | $812.92 | 56 | $0 (2024) |
| MDD US Operations, LLC | $700.04 | 3 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $530.96 | 5 | $0 (2019) |
| Eisai Inc. | $363.51 | 3 | $0 (2021) |
| Biogen, Inc. | $306.77 | 7 | $0 (2023) |
| SK Life Science, Inc. | $249.93 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,018 | 135 | ABBVIE INC. ($16,094) |
| 2023 | $18,214 | 131 | ABBVIE INC. ($16,919) |
| 2022 | $64,390 | 148 | ABBVIE INC. ($50,753) |
| 2021 | $123,812 | 238 | AbbVie Inc. ($91,029) |
| 2020 | $24,712 | 110 | Allergan, Inc. ($21,891) |
| 2019 | $1,683 | 53 | Allergan Inc. ($503.19) |
| 2018 | $744.26 | 28 | Allergan Inc. ($360.25) |
| 2017 | $683.71 | 14 | Allergan Inc. ($239.16) |
All Payment Transactions
857 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: PAIN | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: PAIN | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $102.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/18/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: PAIN | ||||||
| 10/16/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $156.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $0.03 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 583 | 916 | $229,487 | $64,013 |
| 2022 | 12 | 622 | 918 | $186,000 | $71,048 |
| 2021 | 12 | 569 | 858 | $161,473 | $69,912 |
| 2020 | 18 | 752 | 1,143 | $192,805 | $80,650 |
Total Patients
2,526
Total Services
3,835
Medicare Billing
$285,623
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 95 | 198 | $31,680 | $11,468 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 86 | 118 | $37,514 | $11,306 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 91 | 145 | $27,634 | $9,507 | 34.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 47 | $20,915 | $6,120 | 29.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 22 | 64 | $21,825 | $5,521 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 37 | 37 | $16,324 | $4,566 | 28.0% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Facility | 2023 | 16 | 46 | $13,535 | $3,809 | 28.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 39 | $11,700 | $3,433 | 29.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 83 | 85 | $31,025 | $3,391 | 10.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 20 | $4,600 | $1,847 | 40.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 35 | $3,850 | $1,288 | 33.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 14 | 28 | $5,644 | $976.22 | 17.3% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 20 | 54 | $3,240 | $783.12 | 24.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 97 | 139 | $26,235 | $14,287 | 54.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 81 | 81 | $36,045 | $12,103 | 33.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 111 | 198 | $31,680 | $10,937 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 99 | 141 | $19,170 | $9,783 | 51.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 61 | 61 | $15,750 | $7,229 | 45.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 17 | 51 | $7,534 | $4,621 | 61.3% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Facility | 2022 | 17 | 46 | $6,664 | $3,829 | 57.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 72 | 75 | $27,375 | $3,218 | 11.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 27 | $6,210 | $2,159 | 34.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 17 | 17 | $3,553 | $1,183 | 33.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 14 | 28 | $3,192 | $896.93 | 28.1% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 20 | 54 | $2,592 | $803.01 | 31.0% |
About Dr. Seth Hepner, MD
Dr. Seth Hepner, MD is a Neurology healthcare provider based in Bridgeton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2012. The National Provider Identifier (NPI) number assigned to this provider is 1609131663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seth Hepner, MD has received a total of $251,257 in payments from pharmaceutical and medical device companies, with $17,018 received in 2024. These payments were reported across 857 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($223,719).
As a Medicare-enrolled provider, Hepner has provided services to 2,526 Medicare beneficiaries, totaling 3,835 services with total Medicare billing of $285,623. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Internal Medicine, Neurology
- Location Bridgeton, MO
- Active Since 07/05/2012
- Last Updated 04/30/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1609131663
Products in Payments
- UBRELVY (Drug) $173,375
- NURTEC ODT (Drug) $32,392
- BOTOX (Biological) $22,713
- QULIPTA (Drug) $17,571
- APTIOM (Drug) $530.96
- APOKYN (Drug) $513.84
- Fycompa (Drug) $363.51
- GOCOVRI (Drug) $321.68
- BOTOX (Drug) $291.33
- Aimovig (Biological) $242.37
- ZEPOSIA (Drug) $242.21
- MAYZENT (Drug) $172.58
- TECFIDERA (Drug) $156.02
- VUMERITY (Drug) $139.40
- Epidiolex (Drug) $126.21
- OCREVUS (Biological) $125.00
- XCOPRI (Drug) $125.00
- AUBAGIO (Drug) $124.99
- Cenobamate (Drug) $124.93
- INGREZZA (Drug) $122.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bridgeton
Dr. Siddharth Kaul, Md, MD
Neurology — Payments: $552,004
Neurology $552,004
Dr. Daniel Mattson, Md, MD
Neurology — Payments: $500,463
Neurology $500,463
Dr. Xinrong Lu, M.d, M.D
Neurology — Payments: $22,610
Neurology $22,610
Dr. Amer Alshekhlee, Md, MD
Neurology — Payments: $14,239
Neurology $14,239
Dr. Chizoba Ezepue, Md, MD
Neurology — Payments: $5,505
Neurology $5,505
Dr. Robert Margolis, M.d, M.D
Neurology — Payments: $3,305
Neurology $3,305